Subtype
Pancreatic Neoplasm
CI-CAN-00001356Explore in graph →
Non-malignant988 active trials8 approved drugs63 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001356Explore in graph →
Clinical trials
4,217 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00804336 | Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors | completed | Phase 1 | 22 | Dana-Farber Cancer InstituteOTHER | 1 | Oct 19, 2016 | clinicaltrials |
| NCT00260364 | Combining Erlotinib Plus Bevacizumab and Gemcitabine Plus Capecitabine to Treat Advanced Pancreatic Cancer(TARGET) | completed | Phase 1 / Phase 2 | 44 | Royal Marsden NHS Foundation TrustOTHER | 1 | Oct 14, 2016 |
| clinicaltrials |
| NCT01384253 | Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy | completed | Phase 1 | 18 | Orano Med LLCINDUSTRY | 1 | Sep 30, 2016 | clinicaltrials |
| NCT01521325 | A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers | completed | Phase 1 | 6 | MorphotekINDUSTRY | 1 | Sep 30, 2016 | clinicaltrials |
| NCT01413022 | FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma | completed | Phase 1 | 44 | Washington University School of MedicineOTHER | 1 | Sep 19, 2016 | clinicaltrials |
| NCT02150135 | Effect of Oncothermia on Improvement of Quality of Life in Unresectable Pancreatic Cancer Patients | completed | Phase 1 | 10 | Seoul National University HospitalOTHER | 1 | Sep 7, 2016 | clinicaltrials |
| NCT01935453 | A Phase I Study of Recombinant hGM-CSF Herpes Simplex Virus to Treat Cancer | completed | Phase 1 | 18 | OrienGene Biotechnology Ltd.INDUSTRY | 1 | Sep 1, 2016 | clinicaltrials |
| NCT00681798 | Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas Carcinoma | completed | Phase 1 | 8 | SanofiINDUSTRY | 1 | Aug 29, 2016 | clinicaltrials |
| NCT01488552 | Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer | completed | Phase 1 / Phase 2 | 60 | Pancreatic Cancer Research TeamOTHER | 1 | Aug 18, 2016 | clinicaltrials |
| NCT00588640 | Study of D-Methadone in Patients With Chronic Pain | completed | Phase 1 / Phase 2 | 10 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 10, 2016 | clinicaltrials |
| NCT01304160 | Role of Cyberknife Stereotactic Radiation Therapy (SBRT) Followed by Gemcitabine for Patients With Locally Advanced Pancreatic Cancer | completed | Phase 1 / Phase 2 | 10 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Aug 5, 2016 | clinicaltrials |
| NCT00614653 | Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer | completed | Phase 1 | 17 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2016 | clinicaltrials |
| NCT01204476 | Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma | completed | Phase 1 | 27 | National Cancer Institute (NCI)NIH | 1 | Jul 15, 2016 | clinicaltrials |
| NCT00003157 | Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach | completed | Phase 1 | 26 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 14, 2016 | clinicaltrials |
| NCT01450046 | Vitamin E δ-Tocotrienol Multiple Dose in Healthy Subjects | completed | Phase 1 | 18 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jul 7, 2016 | clinicaltrials |
| NCT02382263 | Nab-paclitaxel in Combination With Gemcitabine in Fragile Patients With Advanced Pancreatic Cancer(FRAGANCE) | completed | Phase 1 / Phase 2 | 224 | PH Research, S.L.OTHER | 1 | Jul 6, 2016 | clinicaltrials |
| NCT00320749 | Capecitabine, Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer | completed | Phase 1 | 21 | Tony Bekaii-SaabOTHER | 1 | Jun 27, 2016 | clinicaltrials |
| NCT00049023 | Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors | completed | Phase 1 | 27 | O'Dorisio, M SOTHER | 1 | Jun 21, 2016 | clinicaltrials |
| NCT01155258 | Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 19 | University of Southern CaliforniaOTHER | 1 | Jun 13, 2016 | clinicaltrials |
| NCT00402025 | Talimogene Laherparepvec in Patients With Unresectable Pancreatic Cancer | completed | Phase 1 | 17 | BioVex LimitedINDUSTRY | 1 | Apr 15, 2016 | clinicaltrials |
| NCT01446952 | Vitamin E δ-Tocotrienol (VEDT) Single Dose in Healthy Subjects | completed | Phase 1 | 18 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Apr 11, 2016 | clinicaltrials |
| NCT01296763 | Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer | completed | Phase 1 | 18 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Mar 22, 2016 | clinicaltrials |
| NCT01446458 | Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer | completed | Phase 1 | 13 | Emory UniversityOTHER | 1 | Mar 22, 2016 | clinicaltrials |
| NCT01274455 | Gene Therapy of Pancreatic Ductal Adenocarcinoma(TherGAP) | completed | Phase 1 | 22 | University Hospital, ToulouseOTHER | 1 | Mar 14, 2016 | clinicaltrials |
| NCT00985777 | Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia | completed | Phase 1 | 26 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 1, 2016 | clinicaltrials |
| NCT00375310 | Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic Cancer | completed | Phase 1 | 27 | Indiana UniversityOTHER | 1 | Feb 29, 2016 | clinicaltrials |
| NCT02154646 | A Study of LY2157299 in Participants With Pancreatic Cancer That is Advanced or Has Spread to Another Part of the Body | completed | Phase 1 | 6 | Eli Lilly and CompanyINDUSTRY | 1 | Feb 10, 2016 | clinicaltrials |
| NCT00008099 | Vaccine Therapy in Treating Patients With Resected or Locally Advanced Unresectable Pancreatic Cancer | completed | Phase 1 | 25 | University of PittsburghOTHER | 1 | Jan 20, 2016 | clinicaltrials |
| NCT00003411 | Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer | completed | Phase 1 | — | University of PittsburghOTHER | 1 | Jan 18, 2016 | clinicaltrials |
| NCT00574977 | Safety Study of Modified Vaccinia Virus to Cancer | completed | Phase 1 | 26 | David BartlettOTHER | 1 | Dec 28, 2015 | clinicaltrials |
| NCT00581815 | Spectroscopy With Surface Coils and Decoupling | completed | Phase 1 | 582 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 28, 2015 | clinicaltrials |
| NCT01298401 | Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the Pancreas | completed | Phase 1 | 8 | Radiation Therapy Oncology GroupNETWORK | 1 | Nov 17, 2015 | clinicaltrials |
| NCT01098344 | MK0752 and Gemcitabine Hydrochloride in Treating Patients With Stage III and IV Pancreatic Cancer That Cannot Be Removed by Surgery | completed | Phase 1 | 44 | Cancer Research UKOTHER | 1 | Oct 14, 2015 | clinicaltrials |
| NCT00397384 | Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer | completed | Phase 1 | 43 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2015 | clinicaltrials |
| NCT01674556 | Ultrasound-assisted Treatment of Inoperable Pancreatic Cancer | completed | Phase 1 | 25 | Haukeland University HospitalOTHER | 1 | Sep 24, 2015 | clinicaltrials |
| NCT01777477 | Adjuvant Effect of Chloroquine on Gemcitabine | completed | Phase 1 | 9 | University of ZurichOTHER | 1 | Sep 22, 2015 | clinicaltrials |
| NCT00593866 | Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer | completed | Phase 1 / Phase 2 | 50 | University of Michigan Rogel Cancer CenterOTHER | 1 | Sep 11, 2015 | clinicaltrials |
| NCT00925769 | ATX Study:A Study of Avastin (Bevacizumab), Tarceva (Erlotinib) and Xeloda (Capecitabine) in Patients With Locally Advanced and/or Metastatic Pancreatic Cancer | completed | Phase 1 | 32 | Hoffmann-La RocheINDUSTRY | 1 | Aug 7, 2015 | clinicaltrials |
| NCT00735306 | Phase I/II Trial of Radiation, Avastin and Tarceva for Pancreatic Adenocarcinoma(TART) | completed | Phase 1 | 12 | Duke UniversityOTHER | 1 | Jun 18, 2015 | clinicaltrials |
| NCT00983268 | Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer | completed | Phase 1 | 21 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jun 15, 2015 | clinicaltrials |
| NCT00544193 | Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer | completed | Phase 1 | 16 | City of Hope Medical CenterOTHER | 0 | Jun 8, 2015 | clinicaltrials |
| NCT01486329 | VXM01 Phase I Dose Escalation Study in Patients With Locally Advanced, Inoperable and Stage IV Pancreatic Cancer | completed | Phase 1 | 72 | Vaximm GmbHINDUSTRY | 1 | Jun 8, 2015 | clinicaltrials |
| NCT02074046 | Safety Study of Cancer Stem Cell Vaccine to Treat Pancreatic Cancer | completed | Phase 1 / Phase 2 | 40 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Jun 3, 2015 | clinicaltrials |
| NCT00743379 | Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 71 | Threshold PharmaceuticalsINDUSTRY | 1 | May 7, 2015 | clinicaltrials |
| NCT00006981 | Immunotoxin Therapy in Treating Patients With Advanced Cancer | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00066651 | Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00019435 | LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00411762 | A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma | completed | Phase 1 / Phase 2 | 25 | Yale UniversityOTHER | 1 | Mar 27, 2015 | clinicaltrials |
| NCT01131234 | Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Dec 23, 2014 | clinicaltrials |
| NCT01834170 | EUS-guided Intratumoral Gemcitabine in Locally Advanced Unresectable Pancreatic Cancer | completed | Phase 1 | 12 | University of TehranOTHER | 1 | Dec 2, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Oct 19, 2016source: clinicaltrials